About Brinton Pharmaceuticals
Brinton Pharmaceuticals is a Healthcare company based in Pune (India) founded in 2014 by Rahul Kundanmal Darda. Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured. Brinton Pharmaceuticals has raised $25.97 million across 11 funding rounds from investors including BlackSoil, India Alternatives and IDBI trustee. The company has 508 employees. Brinton Pharmaceuticals was last valued at $36.54 million in April 2024. Its Indian entity Brinton Pharmaceuticals Limited reported revenue of ₹215 Cr. Brinton Pharmaceuticals offers products and services including Therapeutic Solutions. Its focus areas include Life Sciences, Dermatology, Drugs and Diversified.
Company details
Brinton Pharmaceuticals was founded in 2014 in Pune, India, focusing on the pharmaceutical sector. Formulations are produced for clinical and cosmetic dermatology, respiratory care, gastroenterology, pediatrics, rheumatology, nutraceuticals, and foot care. Research and manufacturing capabilities are integrated to develop treatments addressing skin, gastrointestinal, respiratory, and nutritional health needs. The portfolio includes dermatological treatments, nutritional supplements, and specialized clinical formulations for patient care.
- Headquarters Pune, India
- Employees 508
- Founders Rahul Kundanmal Darda
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website brintonhealth.com
- Social LinkedIn X Facebook YouTube
- Legal Name Brinton Pharmaceuticals Limited
- Date of Incorporation 27 Sep, 2013
- Jurisdiction Pune, Maharashtra, India
- Annual Revenue₹215 Cr
FY 2025 · +15% YoY
- Net Loss-₹6.35 Cr
FY 2025 · -3% margin
- EBITDA₹1.91 Cr
FY 2025 · 1% margin
- Total Equity Funding$25.97M (USD)
in 11 rounds
- Latest Funding Round$361K (USD), Series B
Apr 2024
- InvestorsBlackSoil
& 10 more
- Employee Count508
Associated legal entities of Brinton Pharmaceuticals
Brinton Pharmaceuticals is associated with 2 registered companies on The Company Check; the primary company is Brinton Pharmaceuticals Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Brinton Pharmaceuticals Limited CIN U24232PN2013PLC148971 | Active | 27 Sep 2013 | Pune, Maharashtra | ₹215 Cr | 508 | 9 | View details |
| Brinton Healthcare Limited CIN U24297PN2019PLC187750 | Active | 14 Nov 2019 | Pune, Maharashtra | ₹18.8 Cr | 130 | 7 | View details |
Products & Services of Brinton Pharmaceuticals
Brinton Pharmaceuticals offers a comprehensive portfolio of products and services, including Therapeutic Solutions.
Products that redefine healing through scientific innovation.
Apps and channels of Brinton Pharmaceuticals
its YouTube channel Brinton Pharmaceuticals Ltd. has 23.9K subscribers and 30 videos.
Videos from Brinton Pharmaceuticals
The most watched videos on Brinton Pharmaceuticals's YouTube channel, Brinton Pharmaceuticals Ltd. (23.9K subscribers). Click a video to play it here.
More on Brinton Pharmaceuticals Ltd..
Funding Insights of Brinton Pharmaceuticals
Brinton Pharmaceuticals has successfully raised a total of $25.97M across 11 strategic funding rounds. The most recent funding activity was a Series B round of $361 thousand completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25.97M
- Total Rounds 11
- Last Round Series B — $361,000
- First Round $2.33M
(Feb 2015)
- Investors Count 11
Latest 10 of 11 funding rounds of Brinton Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2024 | $359,535 | Series B | $36.54M | – | |
| Apr 2024 | $361,000 | Series B | – | BlackSoil | – |
| Apr 2024 | $959,496 | Series B | $57.04M | – | |
| Aug 2021 | $671,915 | Series B | $••••• | Winner Family Trust | – |
| Aug 2021 | $672,600 | Series B | – | – | – |
| Dec 2020 | $611,667 | Series B | $••••• | Abhay Darda | – |
| Sep 2020 | $1.36M | Debt – Conventional | – | – | |
| Jun 2019 | $8M | Series A | $••••• | India Alternatives, IDBI trustee | – |
| Jun 2019 | $8M | Series B | – | India Alternatives | – |
| Mar 2017 | $4M | Series A | $••••• | TCHF, Beta Tc Holding | – |
| Date | Valuation | Stage |
|---|---|---|
| Apr 2024 | $36.54M | •••••••• |
| Apr 2024 | $57.04M | •••••••• |
| Aug 2021 | $••••• | •••••••• |
| Dec 2020 | $••••• | •••••••• |
| Jun 2019 | $••••• | •••••••• |
| Mar 2017 | $••••• | •••••••• |
| Feb 2015 | $••••• | •••••••• |
Full valuation and stage history of Brinton Pharmaceuticals
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $36.54M (Apr 2024). 11 investors in total: 7 institutional and 4 angel.
Investors in Brinton Pharmaceuticals
Brinton Pharmaceuticals has secured backing from 11 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include BlackSoil, India Alternatives and IDBI trustee.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multiple sectors are targeted for private equity investments. | winnerfamilytrust.tcc.mode | Mumbai, India | ||
Private equity investment firm | 2011 | india-alt.com | Mumbai, India | |
Private equity fund investing in healthcare and lifesciences in India. | 2021 | tatacapitalhealthcarefund.com | Mumbai, India | |
Multiple sectors are invested in by this private equity firm. | betatcholding.tcc.mode | Singapore, Singapore | ||
Private debt is provided to growth-stage companies by BlackSoil. | 2010 | blacksoil.co.in | Mumbai, India | |
Provides corporate trusteeship services for debentures, securities, and investments. | 2001 | idbitrustee.com | Mumbai, India | |
| betatcholdings.tcc.mode | ||||
SJ Suvarna Jadhav | unknown_d431fc9581eb45298 | |||
AD Abhay Darda | unknown_a980b61fa4f0441ab | |||
GG Geoffrey Gee | unknown_9855b6ea86004de4a |
Investor details for Brinton Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Brinton Pharmaceuticals Limited (Brinton Pharmaceuticals)
Brinton Pharmaceuticals Limited is the primary company behind Brinton Pharmaceuticals. The boards of the 2 registered companies of Brinton Pharmaceuticals currently have 9 directors; the longest-serving is Rahul Kundanmal Darda, appointed in 2019. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rahul Kundanmal Darda DIN 00107237 | Managing Director | 14 Nov 2019 | 6 yrs 11 mo | Brinton Healthcare Limited, Brinton Pharmaceuticals Limited |
| Chaitali Rahul Darda DIN 02660211 | Director | 14 Nov 2019 | 6 yrs 11 mo | Brinton Healthcare Limited, Brinton Pharmaceuticals Limited |
| Kundanmal Amolakchand Darda DIN 08214888 | Director | 14 Nov 2019 | 6 yrs 11 mo | Brinton Healthcare Limited |
| Vijey Christopher James Victor DIN 00629841 | Director | 14 Nov 2019 | 6 yrs 11 mo | Brinton Healthcare Limited, Brinton Pharmaceuticals Limited |
| Shivani Bhasin DIN 00590500 | Nominee Director | 03 Mar 2020 | 6 yrs 7 mo | Brinton Healthcare Limited, Brinton Pharmaceuticals Limited |
| Visalakshi Chandramouli DIN 03594109 | Nominee Director | 03 Mar 2020 | 6 yrs 7 mo | Brinton Healthcare Limited, Brinton Pharmaceuticals Limited |
| Mahendra Pannalal Pitaliya DIN 06528561 | Director | 03 Mar 2020 | 6 yrs 7 mo | Brinton Healthcare Limited |
| Ronak Hemprakash Shah DIN 10560847 | Director | 28 Mar 2024 | 2 yrs 6 mo | Brinton Pharmaceuticals Limited |
| Sudeep Chhallani DIN 06513550 | Director | 28 Mar 2024 | 2 yrs 6 mo | Brinton Pharmaceuticals Limited |
People of Brinton Pharmaceuticals
3 people are tracked at Brinton Pharmaceuticals (3 in leadership); the tracked headcount is 508.
| Name | Role | Group |
|---|---|---|
| Co-Founder & Chairman & Managing Director | Leadership | |
Chandra Prakash Singh | Chief Financial Officer | Leadership |
Vijey Christopher J | Executive Director | Leadership |
Complete people profiles for Brinton Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Brinton Pharmaceuticals
Figures of Brinton Pharmaceuticals Limited, the primary company behind Brinton Pharmaceuticals, for FY 2025. Revenue was ₹215 Cr (+15% year on year). Net loss was -₹6.35 Cr (-3% margin). EBITDA was ₹1.91 Cr (1% margin). Revenue has grown at a compounded annual rate of +27% over three years and +16% over five years.
- ₹215 CrRevenue · FY 2025 · +15% YoY
- -₹6.35 CrNet loss · -3% margin
- ₹1.91 CrEBITDA · 1% margin
- ₹1.09 CrPaid-up capital
- 508Employees (provident fund records)
- +27%Revenue CAGR, 3 years
- +16%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Brinton Pharmaceuticals Limited are on its company page.
Detailed financial statements for Brinton Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Brinton Pharmaceuticals
4 dated milestones of Brinton Pharmaceuticals across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Brinton Pharmaceuticals is founded.
- Funding First funding round of $2.3M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series B, of $361K.
Web traffic of Brinton Pharmaceuticals
The website of Brinton Pharmaceuticals (brintonhealth.com) receives about 8.4K visits a month.
- Monthly visits8.4K
▼ 38.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Brinton Pharmaceuticals
Complete news archive for Brinton Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brinton Pharmaceuticals
Brinton Pharmaceuticals was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Brinton Pharmaceuticals is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Brinton Pharmaceuticals is a funded company, having raised a total of $25.97M across 11 funding rounds to date. The company's 1st funding round was a Series A of $4M, raised on Feb 2015.
Brinton Pharmaceuticals has 508 employees.
The primary company behind Brinton Pharmaceuticals, Brinton Pharmaceuticals Limited, reported revenue of ₹215 Cr for FY 2025, up 15% year on year.
Brinton Pharmaceuticals was founded in 2014 in Pune, India, focusing on the pharmaceutical sector. Formulations are produced for clinical and cosmetic dermatology, respiratory care, gastroenterology, pediatrics, rheumatology, nutraceuticals, and foot care. Research and manufacturing capabilities are integrated to develop treatments addressing skin, gastrointestinal, respiratory, and nutritional health needs. The portfolio includes dermatological treatments, nutritional supplements, and specialized clinical formulations for patient care.
Brinton Pharmaceuticals offers Therapeutic Solutions.
Brinton Pharmaceuticals has 11 investors. Key investors include BlackSoil, India Alternatives, IDBI trustee, Tata Capital Healthcare Fund, and Suvarna Jadhav.
The valuation of Brinton Pharmaceuticals is $36.54M as of Apr 2024.
Brinton Pharmaceuticals is associated with 2 legal entities: Brinton Pharmaceuticals Limited, Brinton Healthcare Limited.
The legal entities of Brinton Pharmaceuticals currently have 11 directors, including Rahul Kundanmal Darda, Chaitali Rahul Darda, Shivani Bhasin and others.